[1]郭炎,黄晶晶,许阳慧,等.安宫牛黄丸治疗肝性脑病的临床研究进展[J].西部中医药,2023,36(12):148-151.[doi:10.12174/j.issn.2096-9600.2023.12.33]
　GUO Yan,HUANG Jingjing,XU Yanghui,et al.Advances in Clinical Researches on An′gong Niuhuang Pills in the Treatment of Hepatic Encephalopathy[J].Western Journal of Traditional Chinese Medicine,2023,36(12):148-151.[doi:10.12174/j.issn.2096-9600.2023.12.33]
点击复制

安宫牛黄丸治疗肝性脑病的临床研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年12期
页码:
148-151
栏目:
研究进展
出版日期:
2023-12-15

文章信息/Info

Title:
Advances in Clinical Researches on An′gong Niuhuang Pills in the Treatment of Hepatic Encephalopathy
作者:
郭炎1, 黄晶晶2, 许阳慧1, 王小娇1, 钟跃学1
1.广西中医药大学，广西 南宁 530001
2.广西中医药大学第一附属医院，广西 南宁 530022
Author(s):
GUO Yan1, HUANG Jingjing2, XU Yanghui1, WANG Xiaojiao1, ZHONG Yuexue1
By analyzing the pathogenesis of hepatic encephalopathy (HE), the disease is one of the common complications of various acute and chronic liver diseases, which is characterized by severe illness and high mortality. An′gong Niuhuang pills could develop sedative and anti-pyretic, anti-inflammatory effects, it could protect nerve cells in human body, promote the metabolism and clearance of toxic substances, correct disorders of amino acid metabolism, protect brain cells and reduce the inhibition of brain cell function by neurotoxic substances. Internal administration of Angong Niuhuang pills, or combined with other drugs for oral use, enema in the treatment of HE could reduce the complications and the mortality of inpatients.
关键词:
安宫牛黄丸; 肝性脑病; 研究进展
Keywords:
′ pills; hepatic encephalopathy; research progress
分类号:
R575
DOI:
10.12174/j.issn.2096-9600.2023.12.33
文献标志码:
A
摘要:
安宫牛黄丸;肝性脑病;研究进展
Abstract:
′ pills;hepatic encephalopathy;research progress

相似文献/References:

[1]马玉珍,毛德文,覃艳新,等.六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响[J].西部中医药,2021,34(05):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
　MA Yuzhen,MAO Dewen,QIN Yanxin,et al.Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin[J].Western Journal of Traditional Chinese Medicine,2021,34(12):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
[2]朱荣火,黄晶晶,杜沅沁,等.中医治疗轻微型肝性脑病研究进展[J].西部中医药,2023,36(05):155.[doi:10.12174/j.issn.2096-9600.2023.05.36]
　ZHU Ronghuo,HUANG Jingjing,DU Yuanqin,et al.Research Progress of TCM Therapy for Minimal Hepatic Encephalopathy[J].Western Journal of Traditional Chinese Medicine,2023,36(12):155.[doi:10.12174/j.issn.2096-9600.2023.05.36]
[3]吴凤兰,廖南盛,卫家润,等.大黄煎剂保留灌肠治疗肝性脑病的技术规范研究进展[J].西部中医药,2023,36(06):141.[doi:10.12174/j.issn.2096-9600.2023.06.34]
　WU Fenglan,LIAO Nansheng,WEI Jiarun,et al.Research Progress of Technical Specification of the Treatment of Hepatic Encephalopathy by Dahuang Decoction Retention Enema[J].Western Journal of Traditional Chinese Medicine,2023,36(12):141.[doi:10.12174/j.issn.2096-9600.2023.06.34]

备注/Memo

备注/Memo:
甘钧元（1994—），男，硕士学位，医师。研究方向：肝纤维化、肝硬化的中西医结合基础与临床研究。国家自然科学基金（81660745，81960910）。
更新日期/Last Update: 2023-12-15